The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma

Published:2016-12 Issue:1 Volume:10 Page:
ISSN:1479-7364
Container-title:Human Genomics
language:en
Short-container-title:Hum Genomics

Author:

Chang Kuang-Leei,Lee Ming-Yung,Chao Wan-Ru,Han Chih-Ping

Funder

National Chung Hsing University and Chung Shan Medical University

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40246-016-0096-9.pdf

Reference10 articles.

1. Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384:1376–88.

2. Chao WR, Lee MY, Lin WL, Koo CL, Sheu GT, Han CP. Assessing the HER2 status in mucinous epithelial ovarian cancer on the basis of the 2013 ASCO/CAP guideline update. Am J Surg Pathol. 2014;38:1227–34.

3. Li XS, Sun J, He XL. Expression of c-myc and mutation of the Kras gene in patients with ovarian mucinous tumors. Genet Mol Res. 2015;14:10752–9. doi: 10.4238/2015.September.9.14 .

4. Auner V, Kriegshäuser G, Tong D, et al. Kras mutation analysis in ovarian samples using a high sensitivity biochip assay. BMC Cancer. 2009;9:111.

5. Perren TJ. Mucinous epithelial ovarian carcinoma. Ann Oncol. 2016;27 suppl 1:i53–7. doi: 10.1093/annonc/mdw087 .

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now?;Diagnostics;2024-04-16

2. HER2/ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors;International Journal of Gynecological Pathology;2023-06-30

3. Rare Epithelial Ovarian Cancers: Low Grade Serous and Mucinous Carcinomas;Cold Spring Harbor Perspectives in Medicine;2023-06-05

4. Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis;Diagnostic Pathology;2023-04-20

5. CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy;Biomolecules;2023-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3